Effect of oral supplementation of the probiotic capsule UB-01BV in the treatment of patients with bacterial vaginosis

Beneficial Microbes

Volumn 3, Issue 2, 2012, Pages 151-155

  Ratna Sudha, M ^a   Maurya, A K ^b  

^a Unique Biotech Limited   (India)

^b LOKMANYA TILAK MUNICIPAL GENERAL HOSPITAL   (India)

Author keywords

Bacterial vaginosis; Lactic acid bacteria; Probiotics

Indexed keywords

PROBIOTIC AGENT; PROVINORM; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; DIET SUPPLEMENTATION; DRUG CAPSULE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BIFIDUM; LACTOBACILLUS CASEI; LACTOBACILLUS FERMENTUM; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; TREATMENT DURATION; VAGINA DISCHARGE; VAGINAL PRURITUS; VAGINITIS; DIET; INDIA; METHODOLOGY; MICROCAPSULE; ODOR; ORAL DRUG ADMINISTRATION; PATHOLOGY; PH; PHYSIOLOGY; PRURITUS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; CAPSULES; DIET; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; INDIA; LACTOBACILLUS; ODORS; PROBIOTICS; PRURITUS; TREATMENT OUTCOME; VAGINAL DISCHARGE; VAGINOSIS, BACTERIAL;

EID: 84866951486     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2011.0054     Document Type: Article

References (20)

1. Anukam, K.C., Osazuwa, E., Osemene, G.I., Ehigiagbe, F., Bruce, A.W. and Reid, G., 2006. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes and Infection 8: 2772-2776.
2. Bradshaw, C.S., Morton, A.N., Hocking, J., Garland, S.M., Morris, M.B., Moss, L.M., Horvath, L.B., Kuzevska, I. and Fairley, C.K., 2006. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. Journal of Infectious Diseases 193: 1478-1486.
3. Cauci, S., Guaschino, S., Driussi, S., De Santo, D., Lanzafame, P. and Quadrifoglio, F., 2002. Correlation of local interleukin-8 with immunoglobulin A against Gardnerella vaginalis hemolysin and with prolidase and sialidase levels in women with bacterial vaginosis. Journal of Infectious Diseases 185: 1614-1620.
4. Donder, G.G., Vereecken, A., Bosmans, E., Dekeersmaecker, A., Salembier, G. and Spitz, B., 2002. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. International Journal of Obstetrics and Gynaecology 109: 34-43.
5. Falagas, M.E., Betsi, G.I. and Athanasio, S., 2007. Probiotics for the treatment of women with bacterial vaginosis. Clinical Microbiology and Infection 13: 657-664.
6. Fredricks, D.N., Fiedler, T.L. and Marrazzo, J.M., 2005. Molecular identification of bacteria associated with bacterial vaginosis. New England Journal of Medicine 353: 1899-1911.
7. French, J.I., McGregor, J.A. and Parker, R., 2006. Readily treatable reproductive tract infections and preterm birth among black women. American Journal of Obstetrics and Gynecology 194: 1717-1726.
8. Hapsari, E.D., Hayashi, M. and Matsuo, H., 2006. Clinical characteristics of vaginal discharge in bacterial vaginosis diagnosed by Nugent's criteria. Clinical and Experimental Obstetrics and Gynecology 33: 5-9.
9. Hillier, S.L., Lipinski, C., Briselden A.M. and Eschenbach, D.A., 1993. Efficacy of intravaginal 0.75% metronidazole gel for the treatment of bacterial vaginosis. Obstetrics and Gynecology 81: 963-967.
10. Hillier, S.L., 2005. The complexity of microbial diversity in bacterial vaginosis. New England Journal of Medicine 353: 1886-1887.
11. Keane, F.E., Ison, C.A. and Taylor-Robinson, D., 1997 A longitudinal study of the vaginal flora over a menstrual cycle. International Journal of STD and AIDS 8: 489-494.
12. Myer, L., Denny, L., Telerant, R., Souza, M., Wright Jr., T.C. and Kuhn, L., 2005. Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. Journal of Infectious Diseases 192: 372-1380.
13. Ness, R.B., Kip, K.E., Soper, D.E., Stamm, C.A., Rice, P. and Richter, H.E., 2006. Variability of bacterial vaginosis over 6- to 12-month intervals. Sexually Transmitted Diseases 33: 381-385.
14. Reid, G., Beuerman, D., Heinemann, C. and Bruce, A., 2001 Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunology and Medical Microbiology 32: 37-41.
15. Reid, G., Charbonneau, D., Erb, J., Kochanowski, B., Beuerman, D., Poehner, R. and Bruce, A.W., 2003. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunology and Medical Microbiology 35: 131-134.
16. Schwebke, J.R., Richey, C.M. and Weiss, H.L., 1999. Correlation of behaviors with microbiological changes in vaginal flora. Journal of Infectious Disease 180: 1632-1636.
17. Shalev, E., Battino, S., Weiner, E., Colodner, R. and Keness, Y., 1996. Ingestion of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Archives of Family Medicine 5: 593-596.
18. Sobel, J.D., Ferris, D., Schwebke, J., Nyirjesy, P., Wiesenfeld, H.C., Peipert, J., Soper, D., Ohmit, S.E. and Hillier, S.L., 2006 Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis, American Journal of Obstetrics and Gynecology 194: 1283-1289.
19. Tannock, G.W., Fuller, R., Smith, S.L. and Hall, M.A., 1990. Plasmid profiling of members of the family Enterobacteriaceae, lactobacilli, and bifidobacteria to study the transmission of bacteria from mother to infant. Journal of Clinical Microbiology 28: 1225-1228.
20. Ya, W., Reifer, C. and Miller, L.E., 2010. Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study. American Journal of Obstetrics and Gynecology 203: 120e1-6.